Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewSJ 1008030 is a potent and selective JAK2 Degrader (PROTAC®). This compound shows potent antileukemic efficacy in CRLF2r ALL (Acute Lymphoblastic Leukemia) cell lines (EC50 = 5.4 nM). SJ 1008030 induces dose-dependent JAK2 degradation (IC50 = 32 nM) in xenograft models of kinase-driven ALL, with no effect on GSPT1 levels.
JAK2 antibodies validated for Western Blot also available: Catalog # NBP2-59451 and AF2988.
PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
Sold under license from St. Jude Children's Research Hospital
分子量 | 987.97 |
公式 | C42H43N13O7S.CF3CO2H |
储存 | Store at -20°C |
纯度 | ≥98% (HPLC) |
CAS Number | 2863634-97-1 |
InChI Key | RRJQTSMHAOAMTD-UHFFFAOYSA-N |
Smiles | CCS(=O)(N1CC(C1)(N2C=C(C3=C4C=CNC4=NC(NC5=CC=C(C(NCCN6CCN(C7=CC=C8C(N(C(C8=C7)=O)C9CCC(NC9=O)=O)=O)CC6)=O)C=C5)=N3)C=N2)CC#N)=O.OC(C(F)(F)F)=O |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
溶剂 | 最高浓度 mg/mL | 最高浓度 mM | |
---|---|---|---|
溶解性 | |||
DMSO | 49.4 | 50 |
以下数据基于产品分子量 987.97。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
浓度/溶剂体积/质量 | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.5 mM | 2.02 mL | 10.12 mL | 20.24 mL |
2.5 mM | 0.4 mL | 2.02 mL | 4.05 mL |
5 mM | 0.2 mL | 1.01 mL | 2.02 mL |
25 mM | 0.04 mL | 0.2 mL | 0.4 mL |
参考文献是支持产品生物活性的出版物。
Chang et al (2021) Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia. Blood 138 2313 PMID: 34110416
Constantinescu et al (2021) Degrading JAK2 in ALL by ruxolitinib-based PROTACs. Blood 138 2301 PMID: 34882211
If you know of a relevant reference for SJ 1008030, please let us know.
关键词: SJ 1008030, SJ 1008030 supplier, SJ1008030, protacs, active, degraders, selective, JAK2, kinases, degrades, proteolysis, targeting, chimeras, PROTAC, PROTACS, targeted, protein, degradation, tpd, baricitinib, JAK, Kinase, Degraders, 7675, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。
目前没有 SJ 1008030 的引用文献。 您是否知道使用了 Tocris SJ 1008030 的优秀论文? 请告知我们.
目前没有该产品的评论。 Be the first to review SJ 1008030 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。
This brochure highlights the tools and services available from Bio-Techne to support your Targeted Protein Degradation and Induced Proximity research, including:
Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia